| 题名 | Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial |
| 链接 | http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(16)30531-9/abstract |
| 欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |